GORD132

About Gordion BIoscience

Gordion Bioscience is a private, preclinical-stage biotech based in San Diego and Cambridge, operating at the intersection of genomics, machine learning, and oncology. The company's core platform analyzes comprehensive patient tumor genomic data to identify novel, 'invisible' targets and associated predictive biomarkers, aiming to de-risk drug development from the start. Its pipeline includes in-house bispecific antibody programs and an out-licensed program, with a strategic focus on overcoming resistance mechanisms. Backed by academic founders and a scientific advisory board, Gordion is positioned to address significant unmet needs in precision oncology.

Therapeutic Areas